Bayesian Group Shrinkage model to Identify the Key Genera in Microbiome-Metabolite Relation Dynamics

Priyam Das Co-Author
Virginia Commonwealth University
 
Tanujit Dey Co-Author
Brigham and Women's Hospital, Harvard University
 
Christine Peterson Co-Author
University of Texas MD Anderson Cancer Center
 
Sounak Chakraborty First Author
University of Missouri-Columbia
 
Sounak Chakraborty Presenting Author
University of Missouri-Columbia
 
Sunday, Aug 3: 4:35 PM - 4:50 PM
2059 
Contributed Papers 
Music City Center 
The gut microbiome influences cancer therapy responses, particularly immunotherapies, by shaping the metabolome. While some studies examine specific microbial genera and metabolites, little work identifies key genera driving overall metabolome profiles. To address this, we introduce B-MASTER (Bayesian Multivariate Analysis for Selecting Targeted Essential Regressors), a fully Bayesian framework with L1 and L2 penalties for sparsity and shrinkage, paired with a scalable Gibbs sampler. B-MASTER enables full posterior inference for models with up to four million parameters efficiently. Using this approach, we identify key microbial genera shaping metabolite profiles and analyze their relevance to colorectal cancer.

Keywords

Bayesian penalized regression,

Gibbs sampling

Scalable high-dimensional models

Microbiome-metabolites dynamics

Colorectal cancer. 

Main Sponsor

Biometrics Section